Blood Tests

It’s a tough question to think about, but it could yield a life-altering response depending on how you decide. If you’re having memory or word-retrieval problems, or in some other way are beginning to experience symptoms that may reflect cognitive decline, would you want to know if you are in…

How long you live, and how well you live, especially in your later years, is the result of a complex array of factors. While genetics can play a role, it’s usually more likely that where you live and how you’ve lived your previous years are much more influential in how…

If it feels like there’s an onslaught of information these days about how to diagnose and treat Alzheimer’s dementia, your feelings are valid. New developments and research are coming fast and furious, as academic researchers and for-profit companies race to find effective ways to diagnose Alzheimer’s as early as possible…

In the evolving landscape of the diagnosis and treatment of Alzheimer’s, updates and insights are regularly advancing. We’ve previously reported on the introduction and demise of the first breakthrough “treatment”- Aduhelm- and then on the introduction of Leqembi, the IV-administered antibody intended to slow down the pace of cognitive decline…

There’s no doubt that we have entered an era when important opportunities will exist to delay or diminish the symptoms of dementia. As we’ve been covering in agebuzz, there is now a new drug (Leqembi) available to delay impairment and decline in patients with mild cognitive impairment or the early…

As a follow-up to our previous article portending the next new drug for Alzheimer’s, the FDA has now given approval under its accelerated approval pathway to the new medication Leqembi (originally known as Lecanemab). This drug was developed to help slow down cognitive decline in those with Mild Cognitive Impairment…